ALLSCHWIL and BASEL, Switzerland, Jan. 21, 2008 (PRIME NEWSWIRE) -- Actelion Ltd (VTX:ATLN) (Other OTC:ALIOF) today announced un-audited 2007 total net revenues of CHF 1'317.4 million (FY 2006: CHF 945.7 m). This performance is the result of strong product sales, driven by Tracleer(r). In 2007, Actelion’s lead product for the treatment of Pulmonary Arterial Hypertension achieved total sales of CHF 1'178.6 million (FY 2006: 898.7 m), with continuous growth recorded in all territories worldwide.
